Turning bottlenecks into breakthroughs in gene therapy manufacturing
In late 2023, the first CRISPR-based gene therapy for sickle cell disease patients Casgevy, received the seal of approval from…
All articles by
-
-
ADCs: A Primer for the Pharmaceutical Industry
ADCs are precision medicines that hitch a cell-killing drug (the “payload”) to an antibody via a chemical “linker”. The antibody…
-
From Creams to Biologics: Adapting Dermatology Trials to New Therapies
GlobalData estimates suggest that, across seven of the world’s major pharmaceutical markets - the US, the big five in Europe…
-
Biotech to boardroom: How early oncology data builds investor confidence
Developing oncology medications is a complicated and costly process. While clinical trial designs have improved, these trials still face difficulties…
-
From strategy to submission: How your CRO should create value beyond execution
Biopharma innovators are operating in an environment shaped by the medical need for new and advanced therapies, the sheer volume…
-
Digital first: in silico models join the bioprocess revolution
Few industries have innovated more prodigiously than biopharma over recent years. But its adoption of digital innovations has lagged. Today,…
-
Data Points to Potential for Patient Centricity in Rare Disease Trial Success
For health policymakers at a national level, rare diseases are those affecting a tiny fraction of the population. Worldwide, however, this…
-
Novel software solutions can ease transition in an age of clinical supply chain upheaval
The healthcare landscape faces turbulent times. Regulatory pressures, challenges around demand forecasting and an influx of novel therapies are heaping…
-
Pediatric research: how to fix a clinical trial system built for adults
Pediatric clinical trials are often designed according to templates established for adults. Yet there are notable differences between adults and…
-
Modular manufacturing: The key to unlocking mRNA expansion?
The evolving mRNA landscape has been marked by rapid advancements and a broadening scope of applications, primarily driven by the…